Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
  June 5, 2008  
  Volume IX, Issue 40  
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

Short, and Getting Shorter

Here's an update for those who have been following my latest trade on the NASDAQ 100. I jumped into QID a couple of weeks ago on the premise the market was due for a correction, and the NASDAQ 100 would participate in a big way. QID is an ETF that trades inversely to QQQQ- the ETF for the NASDAQ 100. If QQQQ goes up, QID goes down, and vice versa.

I picked up 2,000 shares at $38.67, and have now been in and out of the money three times in a rather trendless but fairly volatile market. The market appears pretty strong right now, so this could be a fool's errand that will cost me some money. However, after two months of pretty uninterrupted appreciation, I felt like the market was ready to cool off for a bit.

Today, on a rally in the QQQQs, I piled in a little deeper. QID closed at $35.53 today, so I'm down about $4k there. However, this security has no problem swinging a point or two in a day or two, so I'm not too concerned.

Here's a chart of the QQQQs. There's a couple of things I like which suggest a move to the downside. First, today's move represented a double top from the high made a few days ago of $50.47.

Secondly, QQQQ has come back up an filled two gaps left from back in December and January. I know they're hard to see on the chart, but I didn't want to make it too big.

I hoping the upside in the market is exhausted right now, and sellers will surface going into the weekend. I haven't set my stop loss yet, but will look to do so if the market chugs much higher from here. Of course, I could be totally misreading this, and the market could simply power higher.

Today, just before the close, I added 50 July 50 QQQQ puts at $1.27 to my account. I was looking at the QID calls, but they had a bigger premium, so I went with the QQQQ puts.

On the option trade, I'm not going to be looking for a huge move- it's a $6400 additional investment, and if I can scalp a few thousand dollars out of the trade I'll be happy. It will lower my cost basis on the QID position. If it moves the other way, I might choose to liquidate those options fairly quickly, take my loss, and get out.

This trade is testing my patience a bit. This trendless market is tough, with the dollar falling a bit today and oil up $5, it seems like a correction might be imminent.

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com
 

  Subscribe  

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

  Refer A Friend  

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.


  Ensure Newsletter Delivery  

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Disclaimer
The OTC Journal Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

(Insert specific company compensation here)

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.


You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt/?.

 

Click Here to View the OTC Journal Disclosure

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

OTCJ: Chu On This
December 16, 2008

Market Summary
Dow 8952.89 -81.80 (-0.91%)
Nasdaq 1628.03 -4.18 (-0.26%)
Russell 2K 505.03 +0.00 (+0.00%)
S&P 500 927.45 +0.00 (+0.00%)
S&P 100 440.83 +0.00 (+0.00%)
Quotes are delayed 20 minutes.

© 2009 OTC Journal